GLP-1 receptor agonist medications like semaglutide injections, while generally well-tolerated, can cause side effects like nausea, vomiting, diarrhea, constipation, and abdominal pain in some people
Patients and clinicians should be aware that reflux-type symptoms are biologically plausible and have been reported in trial settings for this drug class, even if a definitive causal link has not been formally established for retatrutide specifically
For more information on how nature can be used to tackle human biggest challenges, I recommend visiting Biomimicry Institute
Ongoing monitoring Ability to pause or adjust anytime Support throughout the process Semaglutide A once-weekly GLP-1 receptor agonist injection used to treat type 2 diabetes and chronic weight management in adults who are overweight or obese
Others may pause increases until symptoms fully settle
35, 184199.e5